J O'Shaughnessy

Effect of tamoxifen on mammographic density.

D. Venzon, J. O’Shaughnessy, J. Zujewski, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

A randomized phase III study of iniparib (BSI-201) in combination with gemcitabine/carboplatin (G/C) in metastatic triple-negative breast cancer (TNBC).

K Miller, E. Winer, R. Carlson, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Emerging targeted therapies in triple-negative breast cancer.

J. Crown, J. O’Shaughnessy, G. Gullo, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.

F. Holmes, J. O’Shaughnessy, Stephen E. Jones, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

R E Wittes, W. Wilson, S. Steinberg, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.